What are the responsibilities and job description for the Director / Sr. Director, Early Pipeline Commercialization position at Scholar Rock?
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGF?) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company's approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position :
This is an exciting opportunity for a highly analytical and strategic individual to join our team as a Director / Sr. Director of Early Pipeline Commercialization. This role is critical in shaping the future success of our pipeline by providing market-driven insights to inform portfolio prioritization, indication selection, and strategic positioning. You will work cross-functionally with R&D, regulatory, corporate strategy and commercial teams to ensure seamless integration of scientific innovation with market needs. This is a high-impact, high-visibility role with a unique opportunity to lead in an entrepreneurial environment and affect the trajectory of the company's first launch.
Position Responsibilities :
- Portfolio Prioritization :
- Represent commercial perspective to inform portfolio prioritization and shape development strategy to optimize for commercial success
- Strategic Evaluation :
- Evaluate early pipeline opportunities together with Corporate Strategy team to define target product profile, value propositions and early positioning
- Landscape Assessments :
- Conduct in-depth market landscape analyses to understand disease areas, unmet needs, market opportunities, and evolving trends that can influence pipeline strategy.
- Competitive Intelligence :
- Gather and synthesize competitive intelligence, including benchmarking competitors' pipelines, product launches, and clinical developments, to identify risks and opportunities.
- Market Research & Insights :
- Design and implement an aligned internal process along with overseeing primary and secondary market research projects to evaluate the commercial potential of pipeline assets and inform go / no-go decisions for indication prioritization.
- Indication Planning :
- Collaborate with corporate strategy, R&D and clinical development teams to identify and prioritize next indications, considering patient population, treatment paradigm, and competitive landscape.
- Cross-Functional Collaboration :
- Serve as the commercial voice on pipeline asset teams, working closely with R&D, corporate strategy, clinical development, regulatory, and finance to align on program strategy.
Candidate Requirements :
Preferred Experience :
Competencies :
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
